A new model for secondary prevention of stroke: transition coaching for stroke

被引:16
|
作者
Bushnell, Cheryl [1 ]
Arnan, Martinson [1 ]
Han, Sangwon [2 ]
机构
[1] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA
[2] Inje Univ, Sanggye Paik Hosp, Dept Neurol, Coll Med, Seoul, South Korea
来源
FRONTIERS IN NEUROLOGY | 2014年 / 5卷
关键词
stroke secondary prevention; medication adherence; quality improvement; ADHERENCE; PERSISTENCE; MEDICATIONS; INITIATION; DISEASE; RATES;
D O I
10.3389/fneur.2014.00219
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Non-adherence to stroke prevention medications is a risk factor for first-ever and recurrent stroke. As of yet, there are no guidelines for processes to recognize and address medication non-adherence in stroke patients. We developed a new model of post-discharge prevention care that measures and addresses medication-taking (transition coaching for stroke or TRACS). TRACS includes personalized education about risk factors and medications prior to discharge, follow-up telephone calls, and appointments with a stroke nurse practitioner (NP). The stroke NP asks about medication use (persistence) and whether doses are missed (adherence), and helps to solve problems with access to medications or side effects. In an analysis of 142 patients enrolled in TRACS from October 2012 to February 2014, medication persistence (use of medications from discharge to the time of measurement) was about 80%. Medication persistence at NP visit was higher in those patients with a first-ever stroke (78.9%) vs. those with recurrent stroke (60.7%; p = 0.045). Concerted efforts with 2-day RN follow-up calls and earlier NP appointments to improve medication-taking behaviors are underway.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Secondary prevention of ischaemic stroke
    Muller, Claire
    Roizman, Michael
    Wong, Andrew
    INTERNAL MEDICINE JOURNAL, 2019, 49 (10) : 1221 - 1228
  • [42] Secondary Ischemic Stroke Prevention
    Aaron Bangad
    Mehdi Abbasi
    Adam de Havenon
    Neurotherapeutics, 2023, 20 : 721 - 731
  • [43] Secondary Ischemic Stroke Prevention
    Bangad, Aaron
    Abbasi, Mehdi
    de Havenon, Adam
    NEUROTHERAPEUTICS, 2023, 20 (03) : 721 - 731
  • [44] Progress in secondary stroke prevention
    Romano, Jose G.
    Sacco, Ralph L.
    ANNALS OF NEUROLOGY, 2008, 63 (04) : 418 - 427
  • [45] Secondary prevention of ischemic stroke
    Rantanen, K
    Tatlisumak, T
    CURRENT DRUG TARGETS, 2004, 5 (05) : 457 - 472
  • [46] Advances in secondary prevention of stroke
    Williams, A
    PRACTITIONER, 1999, 243 (1596) : 222 - 225
  • [47] Treatment and secondary prevention of stroke
    Singer, A
    LANCET, 2000, 355 (9200): : 321 - 321
  • [48] Pharmacotherapy for the Secondary Prevention of Stroke
    Toyoda, Kazunori
    DRUGS, 2009, 69 (06) : 633 - 647
  • [49] Secondary prevention of stroke - an update
    Forbes, CD
    JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1998, 118 (01): : 15 - 17
  • [50] Clopidogrel for the secondary prevention of stroke
    Diener, HC
    Ringleb, PA
    Savi, P
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (05) : 755 - 764